CompaniesRanked

2874 companies · fiscal year 2025 · SEC EDGAR · September 25, 2026

Healthcare companies with the most cash — page 3

Ranks 201–300 of 321 · Fiscal year 2025 · Data as of September 25, 2026

Cash
#CompanyCashYoY15-year trend
201Universal Health ServicesUHSUS$138M+9.4%
202Syndax PharmaceuticalsSNDXUS$135M−12.4%
203AmarinAMRNIE$135M+11.3%
204Halozyme TherapeuticsHALOUS$134M+15.5%
205Acadia HealthcareACHCUS$133M+74.6%
206Kindercare Learning CompaniesKLCUS$133M+113.7%
207Phathom PharmaceuticalsPHATUS$130M−56.3%
208Monte Rosa TherapeuticsGLUEUS$130M−42.1%
209ValnevaVALNFR$129M−26.3%
210Supernus PharmaceuticalsSUPNUS$128M+85.3%
211Healthcare ServicesHCSGUS$125M+120.5%
212Cooper CompaniesCOOUS$125M+23.8%
213Cadre HoldingsCDREUS$123M−1.6%
214Vireo GrowthVREOFUS$123M+33.7%
215Corcept TherapeuticsCORTUS$120M−5.6%
216Castle BiosciencesCSTLUS$117M−2.5%
217Ideaya BiosciencesIDYAUS$113M+33.7%
218ProgynyPGNYUS$112M−30.9%
219Xeris BiopharmaXERSUS$111M+55.0%
220AdapthealthAHCOUS$106M−3.3%
221Genedx HoldingsWGSUS$105M+23.2%
222Inspire Medical SystemsINSPUS$105M−30.2%
223InogenINGNUS$104M−8.8%
224Lakefront BiotherapeuticsLKFTBE$103M+54.7%
225VericelVCELUS$100M+34.3%
226Addus HomecareADUSUS$98.9M+52.7%
227Natures Sunshine ProductsNATRUS$93.9M+10.9%
228Organogenesis HoldingsORGOUS$93.7M−30.9%
229NovocureNVCR$93.5M−42.9%
230Travere TherapeuticsTVTXUS$93.0M+58.9%
231National HealthcareNHCUS$92.8M+21.9%
232GlaukosGKOSUS$90.8M−46.5%
233Tandem Diabetes CareTNDMUS$90.6M+30.9%
234Avanos MedicalAVNSUS$89.8M−16.6%
235Biocryst PharmaceuticalsBCRXUS$89.7M−14.3%
236Curaleaf HoldingsCURLFUS$89.2M−16.8%
237Brightspring Health ServicesBTSGUS$88.4M+45.0%
238Adma BiologicsADMAUS$87.6M−15.0%
239Ascend WellnessAAWHUS$85.7M−2.9%
240Vanda PharmaceuticalsVNDAUS$84.9M−17.1%
241Stoke TherapeuticsSTOKUS$84.2M−34.2%
242Tactile Systems TechnologyTCMDUS$83.4M−11.6%
243Innovage HoldingINNVUS$83.2M+80.6%
244Orthofix MedicalOFIXUS$82.0M−1.5%
245Aurinia PharmaceuticalsAUPHCA$80.2M−3.9%
246Concentra Group Holdings ParentCONUS$79.9M−56.4%
247TG TherapeuticsTGTXUS$79.1M−56.0%
248Clover Health InvestmentsCLOVUS$78.3M−59.8%
249Establishment LabsESTAVG$75.6M−16.4%
250KamadaKMDAIL$75.5M−3.8%
251MannkindMNKDUS$74.9M+61.6%
252ChemedCHEUS$74.5M−58.2%
253111YICN$73.1M+15.4%
254HarrowHROWUS$72.9M+54.4%
255Encompass HealthEHCUS$72.2M−15.5%
256HUTCHMED (China)HCMHK$71.3M−53.7%
257Adaptive BiotechnologiesADPTUS$70.5M+47.1%
258ArdelyxARDXUS$68.0M+4.7%
259Guardian Pharmacy ServicesGRDNUS$65.6M+1,308.1%
260CaredxCDNAUS$65.4M−43.0%
261ArtivionAORTUS$64.9M+21.4%
262Niagen BioscienceNAGEUS$64.8M+45.6%
263Prestige Consumer HealthcarePBHUS$62.4M+22.6%
264Karyopharm TherapeuticsKPTIUS$60.5M−3.1%
265Cresco LabsCRLBFUS$57.9M−57.9%
266MacrogenicsMGNXUS$57.2M−68.7%
267Phibro Animal HealthPAHCUS$55.5M−17.3%
268Rhythm PharmaceuticalsRYTMUS$54.3M−39.1%
269XencorXNCRUS$54.1M+32.3%
270EvolusEOLSUS$53.8M−38.1%
271VaxartVXRTUS$53.8M+113.3%
272BioventusBVSUS$51.2M+23.2%
273DocgoDCGOUS$51.0M−42.8%
274Fulgent GeneticsFLGTUS$50.2M−9.0%
275HeartflowHTFLUS$44.8M−12.8%
276Porch GroupPRCHUS$44.7M−73.4%
277Arcutis BiotherapeuticsARQTUS$42.9M−39.9%
278Si-BoneSIBNUS$42.2M+20.9%
279AngiodynamicsANGOUS$41.6M−23.0%
280AccurayARAYUS$41.3M−34.0%
281ConmedCNMDUS$40.8M+66.9%
282Rigel PharmaceuticalsRIGLUS$40.6M−28.5%
283National VisionEYEUS$38.7M−47.7%
284TalkspaceTALKUS$37.4M−51.3%
285LifemdLFMDUS$36.8M+5.1%
286EnovisENOVUS$36.4M−24.5%
287U S Physical TherapyUSPHUS$35.6M−14.0%
288AxogenAXGNUS$35.5M+29.0%
289RegenxbioRGNXUS$34.5M−40.1%
290Starling OncologySTLNUS$33.6M−32.4%
291Strata Critical MedicalSRTAUS$31.0M+68.5%
292Puma BiotechnologyPBYIUS$29.6M−57.2%
293Heron TherapeuticsHRTXUS$28.6M+11.0%
294Lemaitre VascularLMATUS$28.2M+10.3%
295NeuroneticsSTIMUS$28.1M+52.4%
296Petmed ExpressPETSUS$26.9M−46.3%
297P3 Health PartnersPIIIUS$25.0M−35.6%
298BioteBTMDUS$24.1M−38.7%
299Jushi HoldingsJUSHUS$24.0M+23.2%
300Glass House BrandsGLASUS$23.4M−36.8%

All figures from SEC filings · FY2025 · 100

see sources

Download this data as a CSV →

Companies with the most cash →

By sector

By country